Cigarette smoking is the first risk factor for lung cancer and one of the leading causes of...
Head of Unit
Education and Academic Background
Alessandro Zerbi was born in Arona (NO) on September 23, 1959. He graduated at the State University of Milan on July 1984; he became specialist on General Surgery at the same University on 1989. From 1987 to 2003 he worked at the Surgical Department of San Raffaele Hospital of Milan directed by Professor Di Carlo. From 2004 to 2009 he directed the Pancreatic Surgery Unit of San Raffaele Hospital. From 2010 on, he became the chief of the Pancreatic Surgery Section at the Humanitas Cancer Center. From 2001 to 2010 he had a role as Professor on Contract in Surgery at the Università Vita Salute of San Raffaele Hospital, and from 2010 to 2014 at the State University of Milan. In December 2013 he obtained the National Academic Qualification as Associate Professor in Surgery. As of 2014 he acts as the President of the Italian Association of Pancreatology (AISP).
Scientific and Research Interests
His main areas of clinical and research interest are the diseases of the pancreas: pancreatic cancer, neuroendocrine tumors, cystic tumors, multidisciplinary approach to pancreatic tumors, acute and chronic pancreatitis and technical aspects of pancreatic surgery. At the beginning of his career he acquired experience on all surgical sectors; in the last years he almost exclusively devoted to pancreatic surgery. Moreover, he is currently involved in many basic researches in pancreatic cancer and endocrine tumors. He broadened his knowledge on pancreatic surgery during the following stages: 1988 at Massachusetts General Hospital, Boston, USA (Prof Warshaw); 1990 and 1995 at Ulm Hospital, Germany (Prof Beger). He wrote as coordinator the Italian Guidelines for Acute Pancreatitis. He contributed to the Italian Guidelines on Chronic Pancreatitis, to the Guidelines on Cystic Pancreatic Tumors and to the Screening Program for Familiar Pancreatic Cancer in Italy. He was the coordinator of a prospective observational study on endocrine pancreato-duodenal tumors and of a randomized, multicenter study on biological supports in pancreatic surgery.
- Zerbi A, Fossati V, Parolini D, Carlucci M, Balzano G, Bordogna G, Staudacher C, Di Carlo V.
Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 1994; 73: 2930-5.
- Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V.
Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection ? Ann Surg Oncol 2008; 15: 1161-8.
- Zerbi A, Falconi M, Rindi G, Delle Fave G, Tomassetti P, Pasquali C, Capitanio V, Boninsegna L, Di Carlo V. Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol 2010; 105: 1421-9.
- Zerbi A, Capitanio V, Boninsegna L, Delle Fave G, Pasquali C, Rindi G, Campana D, Falconi M.
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. HPB 2013; 15: 935-43.
- Ravaioli M, Pinna AD, Francioni G, Montorsi M, Veneroni L, Grazi GL, Palini GM, Gavazzi F, Stacchini G, Ridolfi C, Serenari M, Zerbi A.
A partnership model between high- and low-volume hospitals to improve results in hepatobiliary pancreatic surgery.Ann Surg 2014; 260:871-5. 1.